Table 3.
Clinical classification at 2 years | n | MTR gradient | |
---|---|---|---|
Mean ± SE (pu/mm) | |||
Periventricular (1 to 5 mm) | Deep (6 to 10 mm) | ||
Healthy controls | 37 | −0.033 ± 0.028 | −0.009 ± 0.012 |
Optic neuritis | |||
Did not convert to CDMS | 40 | 0.016 ± 0.029 | 0.020 ± 0.010 |
Converted to CDMS | 18 | 0.132 ± 0.041* | −0.010 ± 0.019 |
Did not convert to McDonald multiple sclerosis | 18 | 0.015 ± 0.048 | 0.021 ± 0.015 |
Converted to McDonald multiple sclerosis | 40 | 0.069 ± 0.028** | 0.006 ± 0.011 |
Optic neuritis group divided according to conversion to CDMS status within 2 years. *Converters versus healthy controls P = 0.001, converters versus non-converters P = 0.020, non-converters versus healthy controls P = 0.221. Optic neuritis group also divided according to conversion to McDonald multiple sclerosis within 2 years. **Converters versus healthy controls P = 0.014; otherwise, no significant differences in gradients detected.